XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 2,165,092 $ 3,293,861
General and administrative 1,980,207 1,717,585
Total operating expenses 4,145,299 5,011,446
Loss from operations (4,145,299) (5,011,446)
Other income (expense):    
Investment income, net 42,804 81,921
Net loss $ (4,102,495) $ (4,929,525)
Weighted average shares outstanding    
Weighted average common shares outstanding - Basic 14,558,186 9,399,831
Weighted average common shares outstanding - Diluted 14,558,186 9,399,831
Net loss per common share    
Net loss per common share - Basic $ (0.28) $ (0.52)
Net loss per common share - Diluted $ (0.28) $ (0.52)